Ian Peikon
Founder at Cajal Neuroscience, Inc.
Profile
Ian Peikon is the founder of Cajal Neuroscience, Inc. which was founded in 2020, where he holds the title of Chief Scientific Officer.
He is currently a Venture Partner at Lux Capital Group LLC since 2019 and a Board Member at Plexium, Inc. since 2022.
Dr. Peikon's former job was as Director-Platform Biology & Technology at Kallyope, Inc. from 2015 to 2019.
He received his undergraduate degree from Duke University in 2009.
Ian Peikon active positions
Companies | Position | Start |
---|---|---|
Lux Capital Group LLC
Lux Capital Group LLC Investment ManagersFinance Lux Capital Group LLC (Lux Capita Group) is a venture capital firm founded in 2000 by Peter Hebert and Josh Wolfe. The firm is headquartered in New York with an additional office in Menlo Park, California. | Consultant / Advisor | - |
Cajal Neuroscience, Inc.
Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery. | Founder | 2020-03-31 |
Plexium, Inc.
Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | Director/Board Member | 2022-07-31 |
Former positions of Ian Peikon
Companies | Position | End |
---|---|---|
Kallyope, Inc.
Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 2019-09-30 |
Training of Ian Peikon
Duke University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Lux Capital Group LLC
Lux Capital Group LLC Investment ManagersFinance Lux Capital Group LLC (Lux Capita Group) is a venture capital firm founded in 2000 by Peter Hebert and Josh Wolfe. The firm is headquartered in New York with an additional office in Menlo Park, California. | Finance |
Cajal Neuroscience, Inc.
Cajal Neuroscience, Inc. BiotechnologyHealth Technology Cajal Neuroscience is a biotechnology company that focuses on discovering new treatments for neurodegeneration. The company is based in Seattle, WA and was founded by Ian Peikon. The company uses advanced technologies such as integrative human genetics, multi-omics, functional genomics, and microscopy to accelerate their target and drug discovery. | Health Technology |
Plexium, Inc.
Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | Health Technology |
Kallyope, Inc.
Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Health Services |
- Stock Market
- Insiders
- Ian Peikon